X6R-11900-10700
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 352 / AL
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-16
- 2021-04-21
- 2021-06-09
- 2021-09-10
-
2022-03-10
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion, loss of taste and smellMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Congestion, loss of taste and smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release